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Abstract
Background: In drug-resistant TB settings, specimen collection is critical for drug-susceptibility testing (DST). This
observational study included multiple specimen types collected from pediatric TB suspects with the aim to determine
diagnostic yield and inform clinical practice in children with drug-resistant and drug-susceptible TB.
Methods: From 03/2009-07/2010, TB suspects aged ≥6 months and ≤12 years were recruited among outpatient and
inpatient settings. Subjects were new TB suspects or had persistent symptoms despite ≥2 months of TB treatment. The
protocol included collection of a single blood and urine specimen, a single sputum induction and, if inpatients and
<5 years of age, collection of 3 gastric aspirates (GA). Samples were cultured on solid and/or liquid media. DST was by
1% proportion method.
Results: Among 118 children with possible, probable or confirmed TB, the mean age was 4.9 years [SD 3.2] and 64
(62%) of those tested were HIV-positive. Eight (7%) subjects were culture-positive from at least one specimen; yield did
not differ by HIV status or TB treatment history. Among those with positive cultures, 7/8 (88%) were from induced
sputum, 5/6 (83%) from GA, 3/8 (38%) from blood, and 3/7 (43%) from urine. In subjects with both induced sputum
and GA collection, sputum provided one additional case compared to GA. Multidrug resistant (MDR)-TB was detected
by urine culture alone in one child >5 years old. Pan-resistant extensively drug resistant (XDR)-TB was identified by
cultures from all sites in one subject.
Conclusions: TB was cultured from HIV-positive and -negative children, and allowed for identification of MDR and
XDR-TB cases. Urine and induced sputum each provided an additional TB diagnosis and, when compared to GA, may
be considered a less invasive, same-day method of specimen collection for childhood TB suspects. This study illustrates
the continued challenges and limitations of available strategies for pediatric TB diagnostics.
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Background
Nearly 500,000 cases of tuberculosis (TB) are estimated
to occur annually among children less than 15 years of
age worldwide [1,2]. However, accurate measures of the
true pediatric TB burden are hindered by challenges in
confirming a diagnosis [3,4]. Clinical and radiological
findings of pediatric TB are often less specific compared
to those among adults. Additionally, smear microscopy
and culture confirmation are limited by perceived diffi-
culties in obtaining adequate specimens and the pauci-
bacillary nature of pediatric TB; the reported culture
yield is between 10-25% [5,6]. Difficulty in TB diagnosis
is magnified in the HIV-infected child as the yield for diag-
nostic evaluation may be diminished by the other mimics of
TB presentation, including opportunistic pulmonary infec-
tions, failure to thrive and HIV-associated lymphadenopathy.
The need for a confirmed diagnosis of TB is becoming
increasingly important in the era of drug-resistant TB
[7,8]. By age strata, children under 15 years of age bear
the highest proportion of multidrug-resistant (MDR)-TB
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among populations outside of eastern and central Europe
[9]. In settings with low TB prevalence, it may be possible
to circumvent the need for culture-confirmation in a child
provided that the drug-susceptibility pattern from the TB
contact is known. However, in settings of high MDR-TB
prevalence, this key information is often unknown and
safe administration of first-line TB treatment without
culture confirmation may be precluded. In the region
surrounding our study site, the Umzinyathi district of
KwaZulu-Natal, South Africa, drug-resistant TB is ex-
ceedingly common: approximately one in three people
with culture confirmed TB have MDR-TB and one in six
have extensively drug resistant (XDR)-TB [10]. Because
nosocomial and community spread of drug-resistant TB
strains have been documented among adults and chil-
dren, knowledge of a patient’s drug-susceptibility pat-
tern is essential to provide optimal treatment [11,12].
Drug-susceptibility testing for TB can be achieved via
mycobacterial culture or newer nucleic acid amplifica-
tion tests; however, the optimal performance of all of
these techniques still depends on adequate specimen col-
lection [13,14].
Systematic evaluation of pediatric sampling methods is
an important area of study to maximize chances of
achieving a pathogen-based diagnosis efficiently. Histor-
ically, gastric aspiration after overnight fasting has been
the accepted method of specimen collection from young
children to evaluate for TB disease. However, the need
for procedural skills and overnight hospitalization often
preclude the use of this invasive test in low resource
areas where the burden of TB may be greatest [15]. In
recent years, less invasive methods of collecting respira-
tory tract specimens, including sputum induction and
nasopharyngeal aspiration, have been evaluated in the
context of research settings [5,16]. Results suggest at
least equivalent yield from induced sputa [17,18] and
nasopharyngeal aspirates [19] compared to gastric aspi-
rates. Among pediatric inpatients from a tertiary center
in Cape Town, South Africa, the culture yield from a single
induced sputum specimen was equivalent to three con-
secutive gastric aspirates [5]. Among pediatric TB suspects
attending a community clinic in Cape Town, positive yield
from sputum induction led to TB treatment initiation in
21.6% additional children compared to clinical diagnosis
[6]. However, the performance of sputum induction has
not been validated in a rural setting under routine clinical
conditions, despite the potential use as a same-day method
of obtaining quality respiratory specimens.
Other specimens, including blood and urine, have not
been thoroughly evaluated for mycobacterial culture
from children. These bodily fluids are more easily obtain-
able than gastric contents and may offer a unique oppor-
tunity for detection among young children, particularly
those with HIV co-infection, who are more likely to
have disseminated forms of TB. Recently, we have found
blood cultures to provide an accessible means of diagnos-
ing drug-susceptible, MDR- and XDR-TB in adults co-
infected with HIV [20]. Therefore, the use of blood and
urine cultures in populations of children with a high
prevalence of HIV may be of additive yield, particularly
when respiratory specimens are difficult to obtain [20-22].
In this study, we aimed to determine the diagnostic yield
of routine sputum, gastric aspirates, blood and urine cul-
tures among pediatric TB suspects at a rural hospital in
South Africa and inform clinical practice.
Methods
Setting
This study was conducted in the rural town of Tugela
Ferry, South Africa. The provincial incidence of TB is es-
timated at 1,100 per 100,000 population annually, with
approximately 11% occurring in children under 10 years
[23]. Approximately 80% of adult and pediatric TB cases
are HIV co-infected [23].
Patients were enrolled from a 355-bed district govern-
ment hospital and affiliated on-site ambulatory depart-
ments consisting of outpatient and casualty departments
as well as an HIV Clinic, all of which serve children.
Relevant inpatient facilities include a 45-bed pediatric
ward.
Study design
We conducted an observational study among children
≥6 months to ≤12 years old enrolled between March
2009 and July 2010. Children suspected to have tubercu-
losis were referred to the study by hospital physicians.
Patients were eligible if they had at least one of the fol-
lowing: chronic cough, failure to improve after pneumo-
nia treatment, contact with a TB case, failure to thrive,
painless superficial lymphadenopathy, signs of meningi-
tis which were not responsive to antibiotics, or chest
radiograph suggestive of TB. Patients were excluded if
they were on anti-TB treatment for >2 days, or recently
defaulted on TB treatment. In addition, all children who
failed to improve clinically despite ≥2 months of TB treat-
ment were eligible for enrollment to enrich sampling of
children who may have drug-resistant TB.
Study procedures
Aside from the intensified specimen collection, the evalu-
ation for tuberculosis was performed per routine practice
as per the hospital physicians. Research interventions in-
cluded structured interviews to obtain demographics,
medical/family histories, and TB exposures; prior history
of TB was verified by searching through hospital DOTS
registers, TB treatment cards and medical charts. Results
of routine clinical investigations including anthropomet-
rics, hemoglobin, albumin, erythrocyte sedimentation rate,
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HIV antibody reactivity, and CD4 percentage (when
applicable) were abstracted from medical charts. Tuber-
culin skin testing was not routinely conducted during the
study period. Chest radiographs were obtained per stand-
ard practice and included predominantly single AP views
which were digitized and systematically interpreted by a
study radiologist (WEB) who was blinded to the patients’
clinical and microbiological results.
As part of the intensified specimen collection protocol,
all participants were to have blood, urine, and sputum
collected. Venous blood (1-5 mLs) was directly inocu-
lated into a Bactec MycoF-lytic bottle (Becton Dickinson,
Sparks, MD, USA), which was stored at room temperature
until incubated in the Bactec automated blood culture
system, typically within 24 hours. Urine samples were
obtained as first-morning, clean-catch specimens from chil-
dren able to spontaneously void, and for younger children
via a sterile bag secured to the perineum after skin disinfec-
tion with alcohol. A minimum of 5 mL of urine was col-
lected and stored at 4°C until processed as detailed below.
Inpatients under 5 years of age had three consecutive
morning gastric aspirates collected after an overnight
fast as per standard protocol [1]. All children underwent
a single sputum induction by the hospital’s trained re-
spiratory physiotherapists following a standard protocol
[1]. Of note, since 2008, the hospital physiotherapy de-
partment has been performing sputum induction rou-
tinely on adult and pediatric patients in an open-air
setting separated from patient areas with personal pro-
tective equipment provided for parents and staff. Gastric
aspirates were performed prior to sputum induction.
Specimens were transported daily to the TB laboratory
at the University of KwaZulu-Natal in Durban where mi-
croscopy, culture, and drug-susceptibility testing was per-
formed. Sputum, gastric aspirate, and urine specimens were
digested and decontaminated by the N-acetyl-L-cysteine
(NALC)-NaOH method. An aliquot was used for fluores-
cent microscopic sputum examination for acid-fast bacilli
(AFB; auramine-stained) and the remainder was split for
parallel culture on Middlebrook 7H11 agar plates and au-
tomated broth culture via the Bactec MGIT-960 system.
Solid cultures were monitored at 21- and 42-days; liquid
cultures were monitored continuously for 42 days. A nega-
tive culture was one without growth in either system after
42 days. For all positive mycobacterial cultures, biochem-
ical testing with niacin accumulation and nitrate re-
duction was used to confirm the species as Mycobacterium
tuberculosis.
Drug-susceptibility testing was performed on all
M. tuberculosis isolates using the 1% proportional
method on Middlebrook agar with standard critical con-
centrations for isoniazid, rifampin, streptomycin, etham-
butol, ofloxacin, kanamycin, capreomycin, ethionamide
and niacinamide [24]. MDR-TB was defined as resistance
to isoniazid and rifampin, while XDR-TB included further
resistance to ofloxacin and at least one injectable agent
(kanamycin or capreomycin). Niacinamide was used as
a proxy for pyrazinamide, and if resistant, confirmatory
testing was performed including evaluation for pyrazina-
midase production and mutations in the pncA gene. If
non-tuberculous mycobacteria were identified, further
speciation or drug-susceptibility testing was not pursued.
The remainder of clinical management, including the
need for any TB treatment, was directed by the child’s
medical doctor according to South African National TB
Control Programme Guidelines [25]. Typically, children
from this region on TB treatment are monitored by the
DOTS Programme nurses, however participants in this
study were asked to return for a follow-up visit with a
study-related pediatrician two months after enrollment
to monitor for symptom resolution and determine final
diagnostic classification.
Definitions
Patients were retrospectively categorized as having pos-
sible, probable, or confirmed TB based on the World
Health Organization (WHO) guidelines [26]. Possible
TB was defined as having a cough for ≥14 days and at
least two of the following symptoms: fever, night sweats,
weight loss, failure to thrive, or painless lymphadenopathy.
Probable TB patients included those who met criteria for
Possible TB and had two of the following in addition:
known TB contact, chest radiograph consistent with TB,
or favorable response to TB treatment after 2 months.
Confirmed TB was defined as having any culture-positive
specimen for M. tuberculosis.
The nutritional status of the children was determined by
calculating height-for-age z scores (HAZ) and weight-for-
age z-scores (WAZ) (AnthroPlus, v1.0.3, WHO). Children
with a Z-score ≤ -2 standard deviations (SD) below the
mean were defined as being malnourished, and those ≤ -3
SD were severely malnourished.
Statistical analysis
We described simple frequencies for exposure variables,
stratified by TB classification (possible, probable or con-
firmed). To determine risk factors associated with prob-
able or confirmed TB, we combined participants with
probable and confirmed TB and compared them to
those with possible TB. Chi-square tests were used for
dichotomized variables; t-test and Wilcoxon rank-sum
tests were used for continuous variables. All analyses
were performed using SAS Statistics 9.2 software (SAS
Institute, Cary, North Carolina, USA).
Ethical considerations
The study was approved by the ethics committees of
University of KwaZulu-Natal, Albert Einstein College of
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Medicine, and Yale University. Permission was also
granted by the KwaZulu-Natal Department of Health.
Written permission from the parent/guardian to partici-
pate in the study, and verbal child assent when applic-
able, was obtained from all participants.
Results
A total of 118 pediatric TB suspects met enrollment
criteria (Figure 1). There were 85 (72%) children cate-
gorized as having possible TB, 25 (21%) as probable
TB, and 8 (7%) had culture-confirmed TB. The mean
age was 4.7 years. Demographic and clinical charac-
teristics are reported in Table 1. Reflective of the high
prevalence of HIV in the community, 59 (50%) children
had at least one HIV-infected member of the household,
while 37 (31%) patients were orphaned by at least one
parent.
Children categorized as probable/confirmed TB were
more likely to report a known TB contact (p = 0.001),
which is likely reflective of the criteria used for the case
definition. Four (3%) children reported contact with a
drug-resistant TB case: none were confirmed to have
drug-resistant TB. The overall prevalence of malnutri-
tion was high (44%); among malnourished children,
severe malnutrition was found in 42 (81%). Among
children tested for HIV, 64 (65%) were HIV-positive,
of which 32 (50%) were receiving anti-retroviral ther-
apy (Table 1).
Laboratory results did not differ significantly between
groups, aside from median hemoglobin level, which
was lower among those categorized with probable/culture
confirmed disease (p = 0.04). Of the 99 (84%) subjects with
a chest radiograph available for review, all 29 (100%) chil-
dren categorized with probable/culture-confirmed disease
had findings suggestive of TB (p = 0.03), which may be re-
flective of the case definition criteria. The 8 (7%) children
enrolled while clinically failing to respond to ≥2 months
of TB treatment were more likely to have probable TB.
The per-patient culture yield for M. tuberculosis was
7% (n = 8). The contribution of each of the diagnostic
methods is shown in Table 2. Smear-positive disease was
seen in 50% of culture-positive cases. Among the five
children who were culture-positive by sequential gastric
aspirates, the yield from the first gastric aspirate was
equivalent to multiple collections. Induced sputum speci-
mens from these five children were also culture-positive.
Sputum induction was well tolerated overall: no child expe-
rienced prolonged respiratory distress, one child required
brief supplemental oxygen and two had post-procedural
vomiting. Respiratory physiotherapists reported ease with
the procedure. However, there were 23 (19%) children who
had unsuccessful collection of respiratory specimens due to
dry cough/insufficient specimen volume and scheduling
limitations between patients and physiotherapists.
One patient was M. tuberculosis culture-positive by the
urine specimen only, despite presenting with pulmonary
Figure 1 Flow diagram of enrollment.
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Table 1 Demographic & clinical information about pediatric TB suspects, N = 118
Total Possible TB Probable & Culture-confirmed TB p-value
n = 118, (%) n = 85, (%) n = 33, (%)
Age, mean years [SD] 4.7 [3.1] 4.9 [3.4] 4.4 [3.2] NS
Female gender, n (%) 53 (45) 39 (46) 14 (42) NS
Mother as primary caregiver 70 (59) 50 (59) 20 (61) NS
Either parent deceased 37 (31) 26 (31) 11 (33) NS
HIV-infected mother 50 (42) 35 (41) 15 (45) NS
Other HIV-infected family member 9 (8) 7 (8) 2 (6) NS
TB contact reported 62 (53) 37 (44) 25 (76) 0.001
Drug-resistant TB contact reported 4 (3) 3 (3) 1 (3) NS
Contact with “chronic cougher” 19 (16) 13 (15) 6 (18) NS
Prior TB 37 (31) 28 (33) 9 (28) NS
Prior hospitalization (≥1) 31 (26) 24 (28) 7 (21) NS
Malnourished 52 (44) 34 (40) 18 (55) NS
Severely malnourished (n, % of malnourished) 42 (81) 26 (76) 16 (89) 0.09
Tested for HIV 99 (84) 73 (86) 26 (79) NS
HIV positive 64 (65) 47 (64) 17 (65) NS
On HAART, n (% of HIV+) 32 (50) 25 (53) 7 (41) NS
CD4%, median [IQR] 16.8 [11.5-22.3] 16.7 [13.7-22.3] 17 [7.28-19.2] NS
Hemoglobin, median g/dL [IQR] 9.9 [8.8-11.2] 10.3 [9.2-11.2] 8.9 [7.3-10.8] 0.04
Albumin, median g/L [IQR] 32.0 [28.1-37.0] 33.9 [29.0-37.0] 28.8 [25.0-30.8] NS
Erythrocyte Sedimentation Rate, median [IQR] 32.0 [14.0-75.0] 30.0 [14.0-75.0] 36.0 [13.5-75.0] NS
Abnormal chest radiograph consistent with TB 84* (85) 55* (79) 29* (100) 0.03
Enrolled while failing ≥2 mo TB treatment 8 (7) 6 (7) 2 (6) NS
Started on TB treatment 59 (50) 37 (44) 22 (67) NS
*Of 99 children with chest radiographs available for review.

















Possible - + - + - - DS 1.3 Negative n/a
Possible - + + + - - DS 2.2 Negative n/a
Possible - + - - - - DS 1.7 Positive 5.3
Possible - - NC NC - + MDR 8.3 Positive 17.4
Probable - + - + - NC DS 2.0 Negative n/a
Probable - + + + + - DS 1.5 Negative n/a
Probable + + NC NC + + DS 7.0 Positive 2.6
Probable + + + + + + XDR 11 Positive 10.9
Total positive
(% of collected)
2 (25) 7 (88) 3 (50) 5 (83) 3 (38) 3 (43)
*TB status prior to obtaining microbiologic confirmation.
**Among the subjects who had positive cultures by gastric aspirates, 4 (80%) demonstrated culture-positivity from all three aspirates while 1 (20%) child only
demonstrated culture-positivity from the first two aspirates and left the hospital prior to collection of the third aspirate.
***DST: drug susceptibility testing.
XDR: extensively drug-resistant tuberculosis. DS: drug susceptible. MDR: multi-drug resistant. NC: not collected.
n/a: not applicable.
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symptoms. While blood cultures were positive in three
culture-confirmed subjects (two who were HIV-positive),
there was no additive yield above sputum. Of potential
alternative diagnoses, cultures did yield non-tuberculous
mycobacteria from the blood (n = 2) and urine (n = 1)
when M. tuberculosis was not found. This study did not
include any other testing to confirm non-TB diagnoses.
Among the eight children with culture-confirmed TB,
two were found to have drug-resistant TB; both were
co-infected with HIV and demonstrated excellent viro-
logic response to antiretroviral medication. One child
with MDR-TB (CD4% = 17.4) was diagnosed by urine
culture only; one child (CD4% = 10.9) was septic with
XDR-TB [27]. Neither of the two children was known to
have contact with a drug-resistant TB case. The child
with XDR-TB was infected with an isolate that was re-
sistant to all nine drugs tested, including those that
make up the backbone of the provincial standard XDR-
TB treatment regimen. Five culture-confirmed cases
were found to be niacinamide resistant, but follow-up
testing revealed all to have pyrazinamidase activity and
none had pncA mutations identified.
Of all participants, 59 (50%) were started on TB treat-
ment – including 8 (13%) who were enrolled while being
on TB treatment for ≥2 months, 44 (75%) who were
started after enrollment, and 7 (12%) who initiated treat-
ment after the two-month follow-up visit. Seven (6%)
subjects had died within two months of enrollment into
the study: three subjects were possible TB cases, two
had probable TB, and two had culture-confirmed disease
including one child with XDR-TB. The majority, n = 6
(86%), were on TB treatment at the time of death. Eighty-
six percent were also HIV-positive.
Discussion
Diagnosis of pediatric TB remains a global public health
and clinical challenge, given the limitations of current
tests and the paucibacillary nature of disease. As the in-
cidence of drug-resistant TB increases, diagnostic con-
firmation and drug-susceptibility testing becomes more
important for appropriate management. In this study, we
examined the diagnostic yield of multiple specimen types
for pediatric TB in a rural, resource-limited operational
setting. We found that, despite intensive specimen collec-
tion, culture confirmation of M. tuberculosis remained low
overall and extrapulmonary specimens did not provide
additive culture yield over respiratory specimens. However,
culture confirmation allowed for identification of drug-
resistant TB in two of eight culture-positive cases, includ-
ing one case of XDR-TB resistant to all nine antibiotics
tested and one case of MDR-TB in whom the diagnosis
was only confirmed via the urine specimen. Additionally,
the diagnostic yield from same-day, outpatient sputum in-
duction was equivalent to that of three, inpatient gastric
aspirates and may provide a practical alternative to speci-
men collection in resource-limited settings.
Clinicians are often dependent upon a clinical means
of diagnosis for pediatric TB suspects. However, the
WHO classification schema used in this study for pos-
sible and probable TB cases was not able to accurately
categorize our participants who were found to have
culture-confirmed disease. In this cohort, 4 of the 8 chil-
dren who had culture-confirmed TB only met symptom
criteria for “possible TB”, emphasizing the limited sensi-
tivity of this schema. Clinical findings can be non-specific
especially in areas, such as ours, with a high prevalence of
HIV and/or malnutrition, each of which may confound
the presentation of other opportunistic infections that
resemble TB. Clinical scoring systems have been used
throughout the world with varying degrees of success, es-
pecially when applied to HIV-prevalent settings [28-31].
Newer clinical consensus guidelines for pediatric pul-
monary TB classification have been published, [32] which
holds promise for improving classification. But an accept-
able and feasible gold standard diagnostic test for children
remains elusive.
Abnormal findings by chest radiograph were associ-
ated with probable/culture-confirmed disease in this co-
hort. Radiologic findings can often provide objective data
to support a diagnosis of TB disease [33]. However, given
the spectrum of radiographic manifestations based on age,
disease stage and severity, and host immune competence,
the specificity may be low and expertise at pediatric radi-
ography is required locally, which may not be routinely
available in rural settings. The ongoing installation of
digital radiographic units in resource-limited regions will
allow for rapid consultation with radiologists experienced
in pediatric radiology by internet or cell-phone data trans-
mission [34]. Until improved diagnostic capabilities are
available, emphasis should be placed on accurate classifi-
cation of pediatric chest radiographs at the local level as a
helpful diagnostic aid [35].
The diagnosis of drug-resistant TB cannot accurately
be made on clinical grounds alone and requires an ad-
equate specimen for culture or molecular testing. In this
high drug-resistant TB and HIV prevalence setting, we
found two confirmed drug-resistant TB cases out of the
eight culture-positive cases in total; both drug-resistant
cases were among HIV-co-infected children. Import-
antly, neither child was known to have contact with a
drug-resistant TB case, so would not have been identi-
fied as “high-risk” by epidemiologic exposure history. In-
creasing data have shown that treatment of pediatric
MDR-TB [36,37] and XDR-TB [12], even in high HIV
prevalence settings, has excellent outcomes. In addition,
transmission of TB from children has been demon-
strated [38,39]. Thus, accurate diagnosis of MDR- and
XDR-TB in children has great potential to both save
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lives and reduce transmission. But, the low yield from
current diagnostic tests remains a challenge.
An important finding from this study is the yield and
feasibility of sputum induction performed at this rural
district-level hospital under routine clinical conditions.
Here, sputum induction was tolerated without signifi-
cant adverse effects and provided equivalent yield to
multiple gastric aspirates, consistent with studies in re-
ferral centers in South Africa [5]. Sputum induction is
an attractive diagnostic alternative for resource-limited
settings as it offers practical advantages of a same-day
procedure, while also providing an adequate specimen
for culture or molecular-based diagnostics [14]. While
HIV status did not seem to affect culture-positivity, our
small sample size limits our ability to detect whether
HIV status or other risk factors truly affected the yield
from extra-pulmonary specimens. Additionally, a subset
of patients enrolled from the outpatient setting were not
able to successfully undergo the procedure.
The culture yield in our study was lower than ex-
pected from this TB-endemic region, though falls within
the range of published studies from settings with high
HIV prevalence [14,15,40]. In comparison to other pub-
lished studies, our low yield may be explained by the
rural district setting of this study site compared to urban
referral centers, as the latter may see a higher proportion
of TB suspects with later-stage presentations and higher
bacillary burden. A proportion of children did not have
all specimens collected for various reasons including: in-
adequate fasting for sputum induction, in adequate time
available for sputum induction, dry cough/insufficient
specimen volume, inability to produce urine during the
outpatient encounter, and unsuccessful phlebotomy/in-
sufficient specimen volume. Additionally, our yield may
have been affected by the lower specificity of clinical diag-
noses and the presence of other pulmonary infections
mimicking TB in this cohort with a high prevalence of
HIV and severe malnutrition. The broad eligibility criteria
may have played a role in the low culture rate as evi-
denced by only 28% of subjects who met criteria for prob-
able/confirmed TB and the relatively low proportion of
children overall who were deemed to require TB treat-
ment based on clinical criteria. As a result, the low culture
yield limited our ability to identify risk factors for con-
firmed TB disease in this study. Overall, these limitations
hindered our ability to draw definitive conclusions and
further, larger prospective studies are needed.
Conclusions
Although greater attention to TB diagnosis in recent years
has led to landmark gains, the majority of this benefit has
been realized in smear-positive patients [41,42]. Since chil-
dren are known to have paucibacillary disease, diagnostics
that focus on the challenges of specimen collection and
unique disease presentation are urgently needed [43].
Owing in part to these challenges, the current burden of
pediatric drug-resistant TB remains unknown, thereby
limiting efforts to advocate for improved diagnostics and
drug formulations for children. It is estimated that only
5% of adult MDR TB cases are diagnosed [44,45]. It is fur-
ther sobering to appreciate that even fewer of the esti-
mated 40,000 cases of pediatric MDR TB are diagnosed.
The undiagnosed and unrecognized epidemic of pediatric
TB is being borne silently by children worldwide. Ending
childhood deaths due to TB requires strengthening of TB
resources and systems as well as new diagnostics and
treatments tailored to the special requirements of children
at risk.
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